1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for CAMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 22, 2026 50.91%
September 21, 2026 82.89%
September 18, 2026 69.60%
September 17, 2026 55.60%
September 16, 2026 39.35%
September 15, 2026 58.11%
September 14, 2026 30.77%
September 11, 2026 52.88%
September 10, 2026 55.56%
September 09, 2026 117.6%
September 08, 2026 166.7%
September 04, 2026 198.0%
September 03, 2026 218.4%
September 02, 2026 143.6%
September 01, 2026 149.3%
August 31, 2026 160.5%
August 28, 2026 180.4%
August 27, 2026 174.2%
August 26, 2026 174.5%
August 25, 2026 185.3%
August 24, 2026 178.7%
August 21, 2026 181.8%
August 20, 2026 189.6%
August 19, 2026 171.9%
August 18, 2026 163.4%
Date Value
August 17, 2026 199.4%
August 14, 2026 251.0%
August 13, 2026 208.2%
August 12, 2026 228.3%
August 11, 2026 206.6%
August 10, 2026 195.1%
August 07, 2026 196.5%
August 06, 2026 196.1%
August 05, 2026 140.1%
August 04, 2026 153.7%
August 03, 2026 155.2%
July 31, 2026 111.7%
July 30, 2026 110.3%
July 29, 2026 95.81%
July 28, 2026 96.55%
July 27, 2026 88.95%
July 24, 2026 64.58%
July 23, 2026 78.11%
July 22, 2026 86.23%
July 21, 2026 100.6%
July 20, 2026 108.8%
July 17, 2026 123.5%
July 16, 2026 159.1%
July 15, 2026 192.4%
July 14, 2026 202.7%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
MannKind Corp. -37.34%
Ocugen, Inc. -25.18%
ACADIA Pharmaceuticals, Inc. 7.66%
Alnylam Pharmaceuticals, Inc. -45.16%
Anika Therapeutics, Inc. 123.7%